20 LATEST RESOURCES (108 INDEXED)
×
Effect of Cenobamate on Cognition in Patients with Drug-Resistant Epilepsy with Focal Onset Seizures: An Exploratory Study · January 2024
Articles
CNS Drugs
×
Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia · December 2023
Articles
CNS Drugs
×
Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study · August 2023
Articles
CNS Drugs
×
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia · July 2023
Articles
CNS Drugs
×
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease · July 2023
Articles
CNS Drugs
×
Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder · July 2023
Articles
CNS Drugs
×
Clonazepam Loading Dose in Status Epilepticus: Is More Always Better? · June 2023
Articles
CNS Drugs
×
Pharmacological Management of Borderline Personality Disorder and Common Comorbidities · May 2023
Articles
CNS Drugs
×
New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder · May 2023
Articles
CNS Drugs
×
Ketamine and Zinc: Treatment of Anorexia Nervosa via Dual NMDA Receptor Modulation · January 2023
Articles
CNS Drugs
×
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data · December 2022
Articles
CNS Drugs
×
Evaluation of a Rapid Topiramate Titration Scheme for the Early Detection of Cognitive Side Effects · November 2022
Articles
CNS Drugs
×
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies · October 2022
Articles
CNS Drugs
×
A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia · June 2022
Articles
CNS Drugs
×
Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain · April 2022
Articles
CNS Drugs